Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03830892 · ClinicalTrials.gov registry record · NA
Effects of E-Cigarette Power and Nicotine Content in Dual Users and Vapers
A NA study, sponsored by Virginia Commonwealth University.
- Terminated
- Registry status
- NA
- Development phase
- 48
- Enrollment target
NCT03830892 is a NA study that was terminated before completion, run by Virginia Commonwealth University. The registered enrollment target is 48 participants.
The verdict
NCT03830892, a NA study, was terminated before completion, sponsored by Virginia Commonwealth University.
- TERMINATED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
Study Summary
This study aims to understand the effects of device power and nicotine concentration on the likelihood that someone would use or abuse e-cigarettes.
Interventions
- OTHER E-cigarette Lab Session 15 watts, 10 mg nicotine
- OTHER E-cigarette Lab Session 15 watts, 30 mg nicotine
- OTHER E-cigarette Lab Session 30 watts, 10 mg nicotine
- OTHER E-cigarette Lab Session 30 watts, 30 mg nicotine
- OTHER Own Brand Session - E-cigarette
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2019-01-18 |
| Est. Completion | 2020-03-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03830892
The ClinicalTrials.gov registry entry for NCT03830892 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which E-cigarette Lab Session 15 watts, 10 mg nicotine is the first listed.
NCT03830892 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03830892 about?
NCT03830892 is a clinical study titled "Effects of E-Cigarette Power and Nicotine Content in Dual Users and Vapers". This study aims to understand the effects of device power and nicotine concentration on the likelihood that someone would use or abuse e-cigarettes.
What is the current status of trial NCT03830892?
This trial is currently terminated. It is a NA study. The enrollment target is 48 participants. The study started on 2019-01-18. Estimated completion is 2020-03-06.
What interventions are being tested in trial NCT03830892?
The interventions under investigation include: E-cigarette Lab Session 15 watts, 10 mg nicotine (OTHER), E-cigarette Lab Session 15 watts, 30 mg nicotine (OTHER), E-cigarette Lab Session 30 watts, 10 mg nicotine (OTHER), E-cigarette Lab Session 30 watts, 30 mg nicotine (OTHER), Own Brand Session - E-cigarette (OTHER).
Who is sponsoring clinical trial NCT03830892?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.